H.U. Group Holdings, Inc.
General ticker "MRCHF" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $1.1B (TTM average)
H.U. Group Holdings, Inc. follows the US Stock Market performance with the rate: 35.7%.
Estimated limits based on current volatility of 0.5%: low 19.66$, high 19.87$
Factors to consider:
- Earnings expected soon, date: 2026-02-09 bmo
- Company pays dividends (annually): last record date 2025-09-30, amount 0.42$ (Y2.11%)
- Current price 15.3% above estimated high
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-03-31 to 2027-03-31
- 2025-03-31 to 2026-03-31 estimated range: [10.30$, 17.24$]
- 2026-03-31 to 2027-03-31 estimated range: [10.40$, 17.32$]
Financial Metrics affecting the MRCHF estimates:
- Positive: with PPE of 49.3 at the end of fiscal year the price was low
- Positive: Operating cash flow per share per price, % of 17.33 > 12.99
- Positive: -5.04 < Operating profit margin, % of 1.09
- Negative: negative Industry operating cash flow (median)
- Negative: 0.01 < Interest expense per share per price, % of 0.47
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: 42.77 < Shareholder equity ratio, % of 49.04 <= 64.37
Short-term MRCHF quotes
Long-term MRCHF plot with estimates
Financial data
| YTD | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating Revenue | ¥260,908.00MM | ¥236,950.00MM | ¥243,025.00MM |
| Operating Expenses | ¥237,527.00MM | ¥240,993.00MM | ¥240,385.00MM |
| Operating Income | ¥23,381.00MM | ¥-4,043.00MM | ¥2,640.00MM |
| Non-Operating Income | ¥-474.00MM | ¥-3,576.00MM | ¥575.00MM |
| Interest Expense | ¥369.00MM | ¥399.00MM | ¥591.00MM |
| R&D Expense | ¥9,556.00MM | ¥0.00MM | ¥0.00MM |
| Income(Loss) | ¥22,907.00MM | ¥-7,619.00MM | ¥3,215.00MM |
| Taxes | ¥7,230.00MM | ¥-66.00MM | ¥483.00MM |
| Profit(Loss)* | ¥15,676.00MM | ¥-7,553.00MM | ¥2,761.00MM |
| Stockholders Equity | ¥150,045.00MM | ¥142,505.00MM | ¥137,112.00MM |
| Inventory | ¥22,128.00MM | ¥22,461.00MM | ¥21,272.00MM |
| Assets | ¥297,924.00MM | ¥290,849.00MM | ¥279,582.00MM |
| Operating Cash Flow | ¥32,535.00MM | ¥16,551.00MM | ¥21,964.00MM |
| Capital expenditure | ¥21,686.00MM | ¥17,557.00MM | ¥10,314.00MM |
| Investing Cash Flow | ¥-29,583.00MM | ¥-16,050.00MM | ¥-15,958.00MM |
| Financing Cash Flow | ¥-5,757.00MM | ¥-5,782.00MM | ¥-5,298.00MM |
| Earnings Per Share** | ¥275.51 | ¥-132.77 | ¥48.59 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.